SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Anne Wilke; Carmen Doebele; Alena Zindel; Kwang Seok Lee; Sara A. Rieke; Michele Ceribelli; Federico Comoglio; James D. Phelan; Clemens Schmitt; et al.

doi:10.1182/blood.2021012081

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Anne Wilke
, Carmen Doebele
, Alena Zindel
, Kwang Seok Lee
, Sara A. Rieke
, Michele Ceribelli
, Federico Comoglio
, James D. Phelan
, Clemens Schmitt
, et al.

Department of Internal Medicine 3 - Hematology and Internal Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	538-553
Number of pages	16
Journal	Blood
Volume	139
Issue number	4
DOIs	https://doi.org/10.1182/blood.2021012081
Publication status	Published - 27 Jan 2022

Fields of science

302024 Haematology
302055 Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood.2021012081

Cite this

@article{649ffcee4bd84186be55deef788d2691,

title = "SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma",

author = "Anne Wilke and Carmen Doebele and Alena Zindel and Lee, \{Kwang Seok\} and Rieke, \{Sara A.\} and Michele Ceribelli and Federico Comoglio and Phelan, \{James D.\} and Clemens Schmitt and \{et al.\}",

year = "2022",

month = jan,

day = "27",

doi = "10.1182/blood.2021012081",

language = "English",

volume = "139",

pages = "538--553",

journal = "Blood",

issn = "1528-0020",

number = "4",

}

TY - JOUR

T1 - SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

AU - Wilke, Anne

AU - Doebele, Carmen

AU - Zindel, Alena

AU - Lee, Kwang Seok

AU - Rieke, Sara A.

AU - Ceribelli, Michele

AU - Comoglio, Federico

AU - Phelan, James D.

AU - Schmitt, Clemens

AU - et al., null

PY - 2022/1/27

Y1 - 2022/1/27

UR - https://www.scopus.com/pages/publications/85123713626

U2 - 10.1182/blood.2021012081

DO - 10.1182/blood.2021012081

M3 - Article

C2 - 34624079

SN - 1528-0020

VL - 139

SP - 538

EP - 553

JO - Blood

JF - Blood

IS - 4

ER -

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this